RICHARDSON, Texas–(BUSINESS WIRE)–#agenticai—MedeAnalytics, a healthcare enterprise data enrichment platform and analytics software-as-a-service (SaaS) leader, RICHARDSON, Texas–(BUSINESS WIRE)–#agenticai—MedeAnalytics, a healthcare enterprise data enrichment platform and analytics software-as-a-service (SaaS) leader,

MedeAnalytics Appoints David Figueredo as Chief Innovation Officer

2026/01/24 06:30
3 min read

RICHARDSON, Texas–(BUSINESS WIRE)–#agenticai—MedeAnalytics, a healthcare enterprise data enrichment platform and analytics software-as-a-service (SaaS) leader, announced the appointment of David Figueredo as Chief Innovation Officer.

With over 20 years of experience spanning healthcare technology, operations, and innovation, David Figueredo, or “Fig” as he is often called, brings a unique ability to translate complex challenges into actionable, AI-driven strategies that fuel growth and deliver measurable impact for payers, providers, and other key stakeholders across the healthcare landscape.

“Fig’s ability to fuse deep healthcare expertise with a forward-thinking approach to AI and data-driven solutions makes him an invaluable addition to our leadership team,” said Steve Grieco, CEO of MedeAnalytics. “His vision for innovation will help us accelerate the development of intelligent workflows and deliver transformative outcomes for our clients across the healthcare ecosystem.”

Fig joins MedeAnalytics following his recent role as Vice President of Innovation at Experian, where he led modernization, applied AI, and new product development initiatives. Prior to that, he served as Chief Operating Officer at WaveHDC, overseeing product and operations until the company was acquired by Experian in 2023, and subsequently rebranded as Patient Access Curator. Earlier in his career, Figueredo held several leadership roles over 15 years at Change Healthcare, where he spearheaded innovation and growth strategies that drove rapid expansion across multiple market segments, helping to develop solutions like Coverage Insight, DSH audit, and Fraud, Waste and Abuse payer solutions such as TPL audit services.

Throughout his career, Fig has consistently delivered growth and measurable outcomes by combining deep healthcare expertise with a creative, data-driven approach to problem-solving and focus on managing the outcomes that matter to payer and providers. His leadership style is rooted in collaboration and innovation, with a focus on designing holistic, AI-powered solutions that enhance outcomes through data, automation, and intelligent workflows.

“I’m excited to join an organization that is boldly connecting data across the healthcare ecosystem. By combining that data with AI, automation, and interoperability, we can fundamentally change how healthcare operates,” Figueredo said. “We’re at a pivotal moment—breaking down silos, accelerating decision-making, and enabling better outcomes with fewer interventions. The future is here, and together we have a powerful opportunity to unlock insight from complexity and build a smarter, more connected healthcare system.”

Figueredo’s appointment underscores MedeAnalytics’ dedication to pioneering AI-driven innovation and delivering intelligent, data-powered solutions that transform operational efficiency, reduce cost and improve care outcomes across the healthcare ecosystem.

About MedeAnalytics

MedeAnalytics is an enterprise healthcare performance improvement company that provides AI-driven insights to power action at scale—driving measurable improvements for payers, providers, and employers. Backed by more than 30 years as a healthcare data and technology leader, the MedeAnalytics Enterprise Healthcare Performance Cloud unifies clinical, claims, financial, and social data into a trusted foundation to improve MLR, reduce cost and administrative burden, increase operational efficiency, and deliver better care outcomes. Built on an AI-native Healthcare Data Management Platform and Health Fabric™, MedeAnalytics’ comprehensive analytics, and AI-driven workflows transform intelligence into accountable execution across value-based care, risk and quality, utilization management, network optimization, population health, and revenue cycle operations.

MedeAnalytics helps organizations move faster from insight to impact with confidence and measurable results. To learn more, visit www.medeanalytics.com or follow MedeAnalytics on LinkedIn.

Contacts

Media Contact:
Jonathan Houghton, Dalton Agency

jhoughton@daltonagency.com

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

Cashing In On University Patents Means Giving Up On Our Innovation Future

Cashing In On University Patents Means Giving Up On Our Innovation Future

The post Cashing In On University Patents Means Giving Up On Our Innovation Future appeared on BitcoinEthereumNews.com. “It’s a raid on American innovation that would deliver pennies to the Treasury while kneecapping the very engine of our economic and medical progress,” writes Pipes. Getty Images Washington is addicted to taxing success. Now, Commerce Secretary Howard Lutnick is floating a plan to skim half the patent earnings from inventions developed at universities with federal funding. It’s being sold as a way to shore up programs like Social Security. In reality, it’s a raid on American innovation that would deliver pennies to the Treasury while kneecapping the very engine of our economic and medical progress. Yes, taxpayer dollars support early-stage research. But the real payoff comes later—in the jobs created, cures discovered, and industries launched when universities and private industry turn those discoveries into real products. By comparison, the sums at stake in patent licensing are trivial. Universities collectively earn only about $3.6 billion annually in patent income—less than the federal government spends on Social Security in a single day. Even confiscating half would barely register against a $6 trillion federal budget. And yet the damage from such a policy would be anything but trivial. The true return on taxpayer investment isn’t in licensing checks sent to Washington, but in the downstream economic activity that federally supported research unleashes. Thanks to the bipartisan Bayh-Dole Act of 1980, universities and private industry have powerful incentives to translate early-stage discoveries into real-world products. Before Bayh-Dole, the government hoarded patents from federally funded research, and fewer than 5% were ever licensed. Once universities could own and license their own inventions, innovation exploded. The result has been one of the best returns on investment in government history. Since 1996, university research has added nearly $2 trillion to U.S. industrial output, supported 6.5 million jobs, and launched more than 19,000 startups. Those companies pay…
Share
BitcoinEthereumNews2025/09/18 03:26
VIRTUAL Bearish Analysis Feb 10

VIRTUAL Bearish Analysis Feb 10

The post VIRTUAL Bearish Analysis Feb 10 appeared on BitcoinEthereumNews.com. VIRTUAL is approaching a critical support test at the 0.55$ level, with RSI at 33
Share
BitcoinEthereumNews2026/02/10 15:15
XRPL Developer Says 100% Taking Profits on XRP at $10, $27

XRPL Developer Says 100% Taking Profits on XRP at $10, $27

An XRPL developer has stirred discussion around profit-taking levels well above today’s price, prompting mixed reactions from XRP holders who favor a never-sell
Share
Coinstats2026/02/10 15:11